Cavernous malformations: Natural history, diagnosis and treatment

Nature Reviews Neurology

Volumn 5, Issue 12, 2009, Pages 659-670

  Batra, Sachin ^a   Lin, Doris ^a   Recinos, Pablo F ^a   Zhang, Jun ^b   Rigamonti, Daniele ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Paul L Foster School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ANTICOAGULATION; BRAIN HEMORRHAGE; BRAIN SURGERY; CAVERNOUS MALFORMATION; CEREBROVASCULAR MALFORMATION; CLINICAL FEATURE; DISEASE COURSE; DRUG SAFETY; GENE MUTATION; HUMAN; IMMUNOMODULATION; NEUROIMAGING; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEIZURE; SPINAL CORD; STEREOTACTIC RADIOSURGERY;

CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; IMMUNOMODULATION; NEUROSURGICAL PROCEDURES; RADIOSURGERY;

EID: 74949134553     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.177     Document Type: Review

References (122)

1. McCormick, W. F. & Nofzinger, J. D. "Cryptic" vascular malformations of the central nervous system. J. Neurosurg. 24, 865-875 (1966).
2. Zabramski, J. M. et al. The natural history of familial cavernous malformations: results of an ongoing study. J. Neurosurg. 80, 422-432 (1994).
3. Moriarity, J. L., Clatterbuck, R. E. & Rigamonti, D. The natural history of cavernous malformations. Neurosurg. Clin. N. Am. 10, 411-417 (1999).
4. Robinson, J. Jr, Awad, I., Magdinec, M. & Paranandi, L. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery 32, 730-735 (1993).
5. Bertalanffy, H. et al. Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg. Rev. 25, 1-53 (2002).
6. Otten, P., Pizzolato, G., Rilliet, B. & Berney, J. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies [French]. Neurochirurgie 35, 128-131 (1989).
7. Mathiesen, T., Edner, G. & Kihlström, L. Deep and brainstem cavernomas: a consecutive 8-year series. J. Neurosurg. 99, 31-37 (2003).
8. Maraire, J. & Awad, I. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery 37, 591-605 (1995).
9. Hsu, F. P. K., Rigamonti, D. & Huhn, S. L. in Cavernous Malformations Ch. 8 (eds Awad, I. A. & Barrow, D.) 87-100 (American Association of Neurological Surgeons, 1993).
10. Zabramski, J. M. et al. The natural history of familial cavernous malformations: results of an ongoing study. J. Neurosurg. 80, 422-432 (1994).
11. Rigamonti, D. et al. Cerebral cavernous malformations. Incidence and familial occurrence. N. Engl. J. Med. 319, 343-347 (1988).
12. Moriarity, J. et al. The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery 44, 1166-1171 (1999).
13. McCormick, W. The pathology of vascular ("arteriovenous") malformations. J. Neurosurg. 24, 807-816 (1966).
14. McCormick, W., Hardman, J. & Boulter, T. vascular malformations ("angiomas") of the brain, with special reference to those occurring in the posterior fossa. J. Neurosurg. 28, 241-251 (1968).
15. Porter, P., Willinsky, R., Harper, W. & Wallace, M. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J. Neurosurg. 87, 190-197 (1997).
16. Aiba, T. et al. Natural history of intracranial cavernous malformations. J. Neurosurg. 83, 56-59 (1995).
17. Al-Shahi Salman, R., Berg, M., Morrison, L., Awad, I. & Angioma Alliance Scientific Advisory Board. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke 39, 3222-3230 (2008).
18. Del Curling, O. Jr, Kelly, D. L. Jr, Elster, A. D. & Craven, T. E. An analysis of the natural history of cavernous angiomas. J. Neurosurg. 75, 702-708 (1991).
19. Kondziolka, D., Lunsford, L. D. & Kestle, J. R. The natural history of cerebral cavernous malformations. J. Neurosurg. 83, 820-824 (1995).
20. Scott, R., Barnes, P., Kupsky, W. & Adelman, L. Cavernous angiomas of the central nervous system in children. J. Neurosurg. 76, 38-46 (1992).
21. Herter, T., Brandt, M. & Szüwart, U. Cavernous hemangiomas in children. Childs Nerv. Syst. 4, 123-127 (1988).
22. Pozzati, E., Acciarri, N., Tognetti, F., Marliani, F. & Giangaspero, F. Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. Neurosurgery 38, 662-669 (1996).
23. Tomlinson, F. H. et al. Angiographically occult vascular malformations: a correlative study of features on magnetic resonance imaging and histological examination. Neurosurgery 34, 792-799 (1994).
24. Clatterbuck, R., Eberhart, C., Crain, B. & Rigamonti, D. Ultrastructural and immunocytochemical evidence that an incompetent blood?brain barrier is related to the pathophysiology of cavernous malformations. J. Neurol. Neurosurg. Psychiatry 71, 188-192 (2001).
25. Rigamonti, D., Johnson, P., Spetzler, R., Hadley, M. & Drayer, B. Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery 28, 60-64 (1991).
26. Baumann, C. et al. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia 48, 559-563 (2007).
27. Tung, H., Giannotta, S., Chandrasoma, P. & Zee, C. Recurrent intraparenchymal hemorrhages from angiographically occult vascular malformations. J. Neurosurg. 73, 174-180 (1990).
28. Frischer, J. et al. Cerebral cavernous malformations: congruency of histopathological features with the current clinical definition. J. Neurol. Neurosurg. Psychiatry 79, 783-788 (2008).
29. Abrahams, N. A. & Prayson, R. A. The role of histopathologic examination of intracranial blood clots removed for hemorrhage of unknown etiology: a clinical pathologic analysis of 31 cases. Ann. Diagn. Pathol. 4, 361-366 (2000).
30. Abdulrauf, S. I, Kaynar, M. Y & Awad, I. A. A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery 44, 41-47 (1999).
31. Amin-Hanjani, S., Ojemann, R. G. & Ogilvy, C. S. in Schmidel & Sweet's Operative Neurosurgical Techniques: Indications. Methods and Results 5th edn vol.2 Ch. 91 (eds Schmidek, H. & Roberts, D.) 1307?1324 (Elsevier, Philadelphia, 2006).
32. Amin-Hanjani, S., Ogilvy, C., Candia, G., Lyons, S. & Chapman, P. Stereotactic radiosurgery for cavernous malformations: Kjellberg's experience with proton beam therapy in 98 cases at the Harvard Cyclotron. Neurosurgery 42, 1229-1236 (1998).
33. Lee, J. et al. Management of intracranial cavernous malformation in pediatric patients. Childs Nerv. Syst. 24, 321-327 (2008).
34. Awad, I. & Jabbour, P. Cerebral cavernous malformations and epilepsy. Neurosurg. Focus 21, e7 (2006).
35. Moran, N. et al. Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J. Neurol. Neurosurg. Psychiatry 66, 561-568 (1999).
36. Stavrou, I., Baumgartner, C., Frischer, J., Trattnig, S. & Knosp, E. Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery 63, 888-896 (2008).
37. Chang, E. et al. Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations. Neurosurgery 65, 31-37 (2009).
38. Casazza, M. et al. Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery 39, 26-32 (1996).
39. Noto, S. et al. Management of patients with cavernous angiomas presenting epileptic seizures. Surg. Neurol. 64, 495-498 (2005).
40. Wang, C., Liu, A., Zhang, J., Sun, B. & Zhao, Y. Surgical management of brain-stem cavernous malformations: report of 137 cases. Surg. Neurol. 59, 444-454 (2003).
41. Bergametti, F. et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 76, 42-51 (2005).
42. Laberge-le Couteulx, S. et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 23, 189-193 (1999).
43. Liquori, C. L. et al. Mutations in a gene encoding a novel protein containing a phosphotyrosinebinding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 73, 1459-1464 (2003).
44. Liquori, C. L. et al. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum. Mutat. 27, 118 (2006).
45. Gunel, M. et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N. Engl. J. Med. 334, 946-951 (1996).
46. Zhang, J., Clatterbuck, R. E., Rigamonti, D., Chang, D. D. & Dietz, H. C. Interaction between KRIT1 and ICAP1β infers perturbation of integrin β1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum. Mol. Genet. 10, 2953-2960 (2001).
47. Hilder, T. L. et al. Proteomic identification of the cerebral cavernous malformation signaling complex. J. Proteome Res. 6, 4343-4355 (2007).
48. voss, K. et al. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics 8, 249-256 (2007).
49. Zawistowski, J. S., Serebriiskii, I. G., Lee, M. F., Golemis, E. A. & Marchuk, D. A. KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum. Mol. Genet. 11, 389-396 (2002).
50. Ma, X. et al. PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol. Biol. Cell 18, 1965-1978 (2007).
51. Uhlik, M. T. et al. Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell Biol. 5, 1104-1110 (2003).
52. Chen, J. N. et al. Mutations affecting the cardiovascular system and other internal organs in zebrafish. Development 123, 293-302 (1996).
53. Stainier, D. Y. et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development 123, 285-292 (1996).
54. Mably, J. D. et al. Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133, 3139-3146 (2006).
55. Shenkar, R., Shi, C., Check, I., Lipton, H. & Awad, I. Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations. Neurosurgery 61, 693-702 (2007). (Pubitemid 350073243)
56. Shi, C., Shenkar, R., Batjer, H., Check, I. & Awad, I. Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. J. Neurosurg. 107, 1023-1026 (2007).
57. Shi, C. et al. Immune response in human cerebral cavernous malformations. Stroke 40, 1659-1665 (2009).
58. Rigamonti, D. et al. The MRI appearance of cavernous malformations (angiomas). J. Neurosurg. 67, 518-524 (1987).
59. Bradac, G., Riva, A., Schörner, W. & Stura, G. Cavernous sinus meningiomas: an MRI study. Neuroradiology 29, 578-581 (1987).
60. Lehnhardt, F. et al. value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation. Arch. Neurol. 62, 653-658 (2005).
61. Dillon, W. Cryptic vascular malformations: controversies in terminology, diagnosis, pathophysiology, and treatment. AJNR Am. J. Neuroradiol. 18, 1839-1846 (1997).
62. Rigamonti, D. & Spetzler, R. The association of venous and cavernous malformations. Report of four cases and discussion of the pathophysiological, diagnostic, and therapeutic implications. Acta Neurochir. (Wien) 92, 100-105 (1988).
63. Brunereau, L. et al. Familial form of cerebral cavernous malformations: evaluation of gradient-spin-echo (GRASE) imaging in lesion detection and characterization at 1.5 T. Neuroradiology 43, 973-979 (2001).
64. Lee, B. et al. MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am. J. Neuroradiol. 20, 1239-1242 (1999).
65. Schmitz, B. L., Aschoff, A. J., Hoffmann, M. H. & Grön, G. Advantages and pitfalls in 3T MR brain imaging: a pictorial review. AJNR Am. J. Neuroradiol. 26, 2229-2237 (2005).
66. Pinker, K. et al. Improved preoperative evaluation of cerebral cavernomas by high-field, highresolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings-preliminary results. Invest. Radiol. 42, 346-351 (2007).
67. Mottolese, C. et al. Central nervous system cavernomas in the pediatric age group. Neurosurg. Rev. 24, 55-71 (2001).
68. vanefsky, M. et al. Correlation of magnetic resonance characteristics and histopathological type of angiographically occult vascular malformations. Neurosurgery 44, 1174-1180 (1999).
69. Willinsky, R. et al. Follow-up MR of intracranial cavernomas. The relationship between haemorrhagic events and morphology. Interv. Neuroradiol. 2, 127-135 (1996).
70. Yun, T. J. et al. A T1 hyperintense perilesional signal aids in the differentiation of a cavernous angioma from other hemorrhagic masses. AJNR Am. J. Neuroradiol. 29, 494-500 (2008).
71. Tong, K. A. et al. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am. J. Neuroradiol. 29, 9-17 (2008).
72. Kharkar, S., Shuck, J., Conway, J. & Rigamonti, D. The natural history of conservatively managed symptomatic intramedullary spinal cord cavernomas. Neurosurgery 60, 865-872 (2007).
73. Kim, D., Park, Y., Choi, J., Chung, S. & Lee, K. An analysis of the natural history of cavernous malformations. Surg. Neurol. 48, 9-17 (1997). (Pubitemid 127739559)
74. Labauge, P., Brunereau, L., Laberge, S. & Houtteville, J. Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations. Neurology 57, 1825-1828 (2001).
75. Brunereau, L. et al. Familial form of intracranial cavernous angioma: MR imaging findings in 51 families. French Society of Neurosurgery. Radiology 214, 209-216 (2000).
76. Denier, C. et al. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann. Neurol. 60, 550-556 (2006).
77. Simard, J., Garcia-Bengochea, F., Ballinger, W. J., Mickle, J. & Quisling, R. Cavernous angioma: a review of 126 collected and 12 new clinical cases. Neurosurgery 18, 162-172 (1986).
78. Duffau, H. et al. Early radiologically proven rebleeding from intracranial cavernous angiomas: report of 6 cases and review of the literature. Acta Neurochir. (Wien) 139, 914-922 (1997).
79. Barker, F. G. 2nd et al. Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system. Neurosurgery 49, 15-24 (2001).
80. Kupersmith, M. et al. Natural history of brainstem cavernous malformations. Neurosurgery 48, 47-53 (2001).
81. Porter, R. et al. Cavernous malformations of the brainstem: experience with 100 patients. J. Neurosurg. 90, 50-58 (1999).
82. Bruneau, M. et al. Early surgery for brainstem cavernomas. Acta Neurochir. (Wien) 148, 405-414 (2006).
83. Ferroli, P. et al. Brainstem cavernomas: long-term results of microsurgical resection in 52 patients. Neurosurgery 56, 1203-1212 (2005).
84. Fritschi, J., Reulen, H., Spetzler, R. & Zabramski, J. Cavernous malformations of the brain stem. A review of 139 cases. Acta Neurochir. (Wien) 130, 35-46 (1994).
85. Zimmerman, R. S., Spetzler, R. F., Lee, K. S., Zabramski, J. M. & Hargraves, R. W. Cavernous malformations of the brain stem. J. Neurosurg. 75, 32-39 (1991).
86. Pozzati, E., Zucchelli, M., Marliani, A. & Riccioli, L. Bleeding of a familial cerebral cavernous malformation after prophylactic anticoagulation therapy. Case report. Neurosurg. Focus 21, e15 (2006).
87. Chibbaro, S. & Tacconi, L. Safety of deep venous thrombosis prophylaxis with low-molecular-weight heparin in brain surgery. Prospective study on 746 patients. Surg. Neurol. 70, 117-121 (2008).
88. Churchyard, A., Khangure, M. & Grainger, K. Cerebral cavernous angioma: a potentially benign condition? Successful treatment in 16 cases. J. Neurol. Neurosurg. Psychiatry 55, 1040-1045 (1992).
89. Ferroli, P. et al. Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol. Sci. 26, 390-394 (2006).
90. Cohen, D., Zubay, G. & Goodman, R. Seizure outcome after lesionectomy for cavernous malformations. J. Neurosurg. 83, 237-242 (1995).
91. Baumann, C. et al. Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 47, 563-566 (2006).
92. Stefan, H. & Hammen, T. Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol. Scand. 110, 393-397 (2004).
93. Paolini, S. et al. Drug-resistant temporal lobe epilepsy due to cavernous malformations. Neurosurg. Focus 21, e8 (2006).
94. Cappabianca, P. et al. Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin. Neurol. Neurosurg. 99, 179-183 (1997).
95. Siegel, A., Roberts, D., Harbaugh, R. & Williamson, P. Pure lesionectomy versus tailored epilepsy surgery in treatment of cavernous malformations presenting with epilepsy. Neurosurg. Rev. 23, 80-83 (2000).
96. Stefan, H. et al. Magnetoencephalography (MEG) predicts focal epileptogenicity in cavernomas. J. Neurol. Neurosurg. Psychiatry 75, 1309-1313 (2004).
97. Cascino, G. Neuroimaging in epilepsy: diagnostic strategies in partial epilepsy. Semin. Neurol. 28, 523-532 (2008).
98. Gross, B., Batjer, H., Awad, I. & Bendok, B. Brainstem cavernous malformations. Neurosurgery 64, e805-e818 (2009).
99. Samii, M., Eghbal, R., Carvalho, G. A. & Matthies, C. Surgical management of brainstem cavernomas. J. Neurosurg. 95, 825-832 (2001).
100. de Oliveira, J., Rassi-Neto, A., Ferraz, F. & Braga, F. Neurosurgical management of cerebellar cavernous malformations. Neurosurg. Focus 21, e11 (2006).
101. D'Angelo, V. et al. Supratentorial cerebral cavernous malformations: clinical, surgical, and genetic involvement. Neurosurg. Focus 21, e9 (2006).
102. Jallo, G., Freed, D., Zareck, M., Epstein, F. & Kothbauer, K. Clinical presentation and optimal management for intramedullary cavernous malformations. Neurosurg. Focus 21, e10 (2006).
103. Pham, M., Gross, B. A, Bendok, B. R, Awad, I. & Batjer, H. Radiosurgery for angiographically occult vascular malformations. Neurosurg. Focus 26, e16 (2009).
104. Liscák, R., Vladyka, V., Simonová, G., vymazal, J. & Novotny, J. J. Gamma knife surgery of brain cavernous hemangiomas. J. Neurosurg. 102 (Suppl.), 207-213 (2005).
105. Liu, K. et al. Gamma knife surgery for cavernous hemangiomas: an analysis of 125 patients. J. Neurosurg. 102 (Suppl.), 81-86 (2005).
106. Chang, S. et al. Stereotactic radiosurgery of angiographically occult vascular malformations: 14-year experience. Neurosurgery 43, 213-220 (1998).
107. Kida, Y., Kobayashi, T. & Tanaka, T. Treatment of symptomatic AOvMs with radiosurgery. Acta Neurochir. Suppl. 63, 68-72 (1995).
108. Pollock, B. E. et al. Stereotactic radiosurgery for cavernous malformations. J. Neurosurg. 93, 987-991 (2000).
109. Régis, J. et al. Radiosurgery for epilepsy associated with cavernous malformation: retrospective study in 49 patients. Neurosurgery 47, 1091-1097 (2000).
110. Hasegawa, T. et al. Long-term results after stereotactic radiosurgery for patients with cavernous malformations. Neurosurgery 50, 1190-1197 (2002).
111. Zhang, J., Clatterbuck, R. E., Rigamonti, D. & Dietz, H. C. Cloning of the murine Krit1 cDNA reveals novel mammalian 5' coding exons. Genomics 70, 392-395 (2000).
112. Zhang, J., Basu, S., Rigamonti, D., Dietz, H. C. & Clatterbuck, R. E. Krit1 modulates β1-integrin-mediated endothelial cell proliferation. Neurosurgery 63, 571-578 (2008).
113. Czubayko, M., Knauth, P., Schluter, T., Florian, v. & Bohnensack, R. Sorting nexin 17, a non-self-assembling and a PtdIns(3)P high class affinity protein, interacts with the cerebral cavernous malformation related protein KRIT1. Biochem. Biophys. Res. Commun. 345, 1264-1272 (2006).
114. Francalanci, F. et al. Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp. Cell Res. 315, 285-303 (2009).
115. Berman, J. R. & Kenyon, C. Germ-cell loss extends C. elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone signaling. Cell 124, 1055-1068 (2006).
116. Bouvard, D. et al. Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1β. J. Biol. Chem. 278, 6567-6574 (2003).
117. Fournier, H. N. et al. Nuclear translocation of integrin cytoplasmic domain-associated protein 1 stimulates cellular proliferation. Mol. Biol. Cell 16, 1859-1871 (2005).
118. Hogan, B. M., Bussmann, J., Wolburg, H. & Schulte-Merker, S. Ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum. Mol. Genet. 17, 2424-2432 (2008).
119. Whitehead, K. J., Plummer, N. W., Adams, J. A., Marchuk, D. A. & Li, D. Y. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131, 1437-1448 (2004).
120. Jin, S.-W. et al. A transgene-assisted genetic screen identifies essential regulators of vascular development in vertebrate embryos. Dev. Biol. 307, 29-42 (2007).
121. Kleaveland, B. et al. Regulation of cardiovascular development and integrity by the heart of glasscerebral cavernous malformation protein pathway. Nat. Med. 15, 169-176 (2009).
122. Whitehead, K. J. et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 15, 177-184 (2009).